HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Characterization of former heroin addict patients with Hepatitis C virus antibodies in a methadone maintenance treatment (MMT) clinic in israel.

AbstractAIMS:
To compare characteristics, retention in treatment and cessation of drug abuse of 249 positive hepatitis C (HCV+) with 188 negative hepatitis C (HCV-) antibody patients.
METHODS:
Data on Hepatitis C, Hepatitis B and HIV results, urine-proven drug use, and modified ASI of all patients admitted to the Adelson MMT clinic between June/1993-Dec/2002 were prospectively collected.
RESULTS:
HCV+ patients manifested more ever injecting drug use, immigrants, positive HIV antibody, hepatitis B antigen, years of opiate addiction pre-MMT and benzodiazepines misuse after one year in MMT than HCV- patients, with similar 1-year retention and proportion of opiate use cessation.
CONCLUSIONS:
Although characteristics of HCV+ and HCV- differed, they manifested similar outcomes: treatment retention and proportion of opiate use cessation.
AuthorsEinat Peles, Vera Rados, Miriam Adelson
JournalSubstance use & misuse (Subst Use Misuse) Vol. 42 Issue 9 Pg. 1477-84 ( 2007) ISSN: 1082-6084 [Print] England
PMID17886143 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Hepatitis C Antibodies
  • Methadone
Topics
  • Adult
  • Female
  • Hepacivirus
  • Hepatitis C Antibodies (analysis)
  • Heroin Dependence (drug therapy, urine)
  • Humans
  • Israel
  • Male
  • Methadone
  • Patient Compliance
  • Prospective Studies
  • Substance Abuse Treatment Centers

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: